Dr. Reddy's enters the trade generics business in India
Dr. Reddy's aims to roll out its trade generics across cities and towns in India
Dr. Reddy's aims to roll out its trade generics across cities and towns in India
The product will be produced at the Eugia Pharma Specialities, Unit-I, Medchal, Malkajgiri District, Telangana, India
The company expects to capture a 10 per cent share in Spain’s $6.34 million meropenem market and consolidate its position in other European countries
Antimicrobial Resistance (AMR) poses a significant threat to global healthcare systems and patient safety
The company will supply materials to all global regions including Asia such as China, India, Europe, and the U.S.
Effective disaster response and management is a collaborative work
This partnership will revolutionize Pharmarack's digital infrastructure with Snowflake's single, integrated platform to facilitate advanced analytic
Subscribe To Our Newsletter & Stay Updated